Fungal infection in co-infected patients with COVID-19: an overview of case reports/case series and systematic review

SS Seyedjavadi, P Bagheri, MJ Nasiri… - Frontiers in …, 2022 - frontiersin.org
Fungal co-infections are frequent in patients with coronavirus disease 2019 (COVID-19) and
can affect patient outcomes and hamper therapeutic efforts. Nonetheless, few studies have …

Clinical features and mortality of COVID-19-associated mucormycosis: a systematic review and meta-analysis

A Watanabe, M So, H Mitaka, Y Ishisaka, H Takagi… - Mycopathologia, 2022 - Springer
The recent increase of COVID-19-associated mucormycosis (CAM) has been commanding
global attention. However, basic epidemiologic characteristics have not firmly been …

[HTML][HTML] Binary ethosomes for the enhanced topical delivery and antifungal efficacy of ketoconazole

AA Aljohani, MA Alanazi, LA Munahhi, JD Hamroon… - OpenNano, 2023 - Elsevier
This work aimed to prepare ketoconazole-loaded ethosomes and binary ethosomes to
improve its skin delivery and antifungal efficacy. A 3 2 factorial design was used to optimize …

Mortality-related risk factors for coronavirus disease (COVID-19)-associated mucormycosis: a systematic review and meta-analysis

VR Ostovan, R Tabrizi, H Bazrafshan… - Current fungal infection …, 2022 - Springer
Abstract Purpose of Review Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-
CoV-2) can increase the susceptibility of individuals to contracting mucormycosis through …

[HTML][HTML] A retrospective analysis of risk factors of Covid-19 associated mucormycosis and mortality predictors: a single-center study

K Zirpe, P Pote, A Deshmukh, SK Gurav, AM Tiwari… - Cureus, 2021 - ncbi.nlm.nih.gov
Background Mucormycosis has been identified with increasing frequency in patients with
coronavirus disease 2019 (COVID-19). Aims We aimed to determine the in-hospital outcome …

Clinical phenotypes of COVID-19 associated mucormycosis (CAM): a comprehensive review

MP Almyroudi, K Akinosoglou, J Rello, S Blot… - Diagnostics, 2022 - mdpi.com
A mucormycosis surge was reported during the COVID-19 pandemic in India. A literature
search until 14 July 2022, with the aim of updating COVID-19-associated mucormycosis …

Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review

PK Baral, MA Aziz, MS Islam - Health Science Reports, 2022 - Wiley Online Library
COVID‐19 is not only limited to a defined array but also has expanded with several
secondary infections. Two uncommon opportunistic fungal infections, COVID‐19 associated …

Using artificial intelligence-based models to predict the risk of mucormycosis among COVID-19 survivors: An experience from a public hospital in India

S Syed-Abdul, AS Babu, RS Bellamkonda, R Itumalla… - Journal of Infection, 2022 - Elsevier
Introduction India reported a severe public health challenge not only due to the COVID-19
outbreak but also the increasing number of associated mucormycosis cases since 2021 …

Onset of mucormycosis in patients with COVID-19: a systematic review on patients' characteristics

S Ghasemi, M Dashti, A Fahimipour… - European Journal of …, 2023 - thieme-connect.com
Mucormycosis has a significant impact on patients' standard of living and, therefore, a high
clinical suspicion, prediagnosis, and rapid treatment are critical in easing patients' suffering …

Various Treatment Modalities in COVID-19 Associated Facial Mucormycosis and the Need for its Surgical Management: A Systematic Review

S Chopra, S Setiya, PP Waknis, L Kale… - Journal of Maxillofacial …, 2023 - Springer
Introduction Mucormycosis emerged as a wildfire in post-covid-19 infected patients. Most
frequently involved sites of mucormycosis are rhino-orbital, rhino-sinusal and rhino-orbito …